These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30953194)

  • 1. Assessment of CD133-positive extracellular membrane vesicles in pancreatic cancer ascites and beyond.
    Fargeas CA; Karbanová J; Corbeil D
    Med Mol Morphol; 2020 Mar; 53(1):60-62. PubMed ID: 30953194
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer.
    Sakaue T; Koga H; Iwamoto H; Nakamura T; Ikezono Y; Abe M; Wada F; Masuda A; Tanaka T; Fukahori M; Ushijima T; Mihara Y; Naitou Y; Okabe Y; Kakuma T; Ohta K; Nakamura KI; Torimura T
    Med Mol Morphol; 2019 Dec; 52(4):198-208. PubMed ID: 30805710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoubiquitination of Cancer Stem Cell Marker CD133 at Lysine 848 Regulates Its Secretion and Promotes Cell Migration.
    Yang F; Xing Y; Li Y; Chen X; Jiang J; Ai Z; Wei Y
    Mol Cell Biol; 2018 Aug; 38(15):. PubMed ID: 29760280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex N-glycan promotes CD133 mono-ubiquitination and secretion.
    Li Y; Shi D; Yang F; Chen X; Xing Y; Liang Z; Zhuang J; Liu W; Gong Y; Jiang J; Wei Y
    FEBS Lett; 2019 Apr; 593(7):719-731. PubMed ID: 30873590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic Tumor Progression Associated With CD133 Overexpression: Involvement of Increased TERT Expression and Epidermal Growth Factor Receptor-Dependent Akt Activation.
    Weng CC; Kuo KK; Su HT; Hsiao PJ; Chen YW; Wu DC; Hung WC; Cheng KH
    Pancreas; 2016 Mar; 45(3):443-57. PubMed ID: 26646272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical detection using CDX2: An aid for discerning tumor involvement in ascites cytology.
    Kobayashi M; Ueyama Y; Nakanishi H; Ishida H; Takahashi E; Nakamura S; Koshikawa T; Yatabe Y
    Cancer; 2006 Apr; 108(2):114-8. PubMed ID: 16541450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells.
    Maeda K; Ding Q; Yoshimitsu M; Kuwahata T; Miyazaki Y; Tsukasa K; Hayashi T; Shinchi H; Natsugoe S; Takao S
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27367674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.
    Joseph C; Arshad M; Kurozomi S; Althobiti M; Miligy IM; Al-Izzi S; Toss MS; Goh FQ; Johnston SJ; Martin SG; Ellis IO; Mongan NP; Green AR; Rakha EA
    Breast Cancer Res Treat; 2019 Apr; 174(2):387-399. PubMed ID: 30554343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve growth factor regulates CD133 function to promote tumor cell migration and invasion via activating ERK1/2 signaling in pancreatic cancer.
    Xin B; He X; Wang J; Cai J; Wei W; Zhang T; Shen X
    Pancreatology; 2016; 16(6):1005-1014. PubMed ID: 27654574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis.
    Durko L; Wlodarski W; Stasikowska-Kanicka O; Wagrowska-Danilewicz M; Danilewicz M; Hogendorf P; Strzelczyk J; Malecka-Panas E
    Dis Markers; 2017; 2017():3276806. PubMed ID: 28659655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative and other posttranslational modifications in extracellular vesicle biology.
    Szabó-Taylor K; Ryan B; Osteikoetxea X; Szabó TG; Sódar B; Holub M; Németh A; Pálóczi K; Pállinger É; Winyard P; Buzás EI
    Semin Cell Dev Biol; 2015 Apr; 40():8-16. PubMed ID: 25721811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic glomerular damage is associated with reduced CD133 expression in urinary extracellular vesicles.
    Dimuccio V; Peruzzi L; Brizzi MF; Cocchi E; Fop F; Boido A; Gili M; Gallo S; Biancone L; Camussi G; Bussolati B
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F486-F495. PubMed ID: 31869243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and proteomic characterization of extracellular vesicles in human pancreatic juice.
    Osteikoetxea X; Benke M; Rodriguez M; Pálóczi K; Sódar BW; Szvicsek Z; Szabó-Taylor K; Vukman KV; Kittel Á; Wiener Z; Vékey K; Harsányi L; Szűcs Á; Turiák L; Buzás EI
    Biochem Biophys Res Commun; 2018 Apr; 499(1):37-43. PubMed ID: 29550476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity.
    Gupta VK; Sharma NS; Kesh K; Dauer P; Nomura A; Giri B; Dudeja V; Banerjee S; Bhattacharya S; Saluja A; Banerjee S
    Cancer Lett; 2018 Dec; 439():101-112. PubMed ID: 30290209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression.
    Nuzhat Z; Kinhal V; Sharma S; Rice GE; Joshi V; Salomon C
    Oncotarget; 2017 Mar; 8(10):17279-17291. PubMed ID: 27999198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cell-derived tissue factor-positive extracellular vesicles: biomarkers of thrombosis and survival.
    Hisada Y; Mackman N
    Curr Opin Hematol; 2019 Sep; 26(5):349-356. PubMed ID: 31261175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles as biomarkers and therapeutic targets for cancer.
    Urabe F; Kosaka N; Ito K; Kimura T; Egawa S; Ochiya T
    Am J Physiol Cell Physiol; 2020 Jan; 318(1):C29-C39. PubMed ID: 31693397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In search of an early warning system for pancreatic cancer.
    Hingorani SR; Tuveson DA
    Cancer Biol Ther; 2003; 2(1):84-6. PubMed ID: 12673125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.